Background: Rosacea is a cutaneous disease that may secondarily affect the ocular surface. Due to the vision threatening, cosmetic, psychological, and work productivity impact, the identification of cellular targets that govern rosacea would enhance our understanding of the biology of the disease and delineate targets for therapeutic manipulation.
Objective: To characterize the involvement of SH2 domain-containing protein tyrosine phosphatase-2 (SHP2) in the pathogenesis of rosacea.
Methods: Specimens from elective ectropion surgery ( = 20) were processed from patients with rosacea ( = 10) and control patients ( = 10). Immunohistochemistry (IHC) and quantitative western blotting (WB) were performed to identify and quantify the presence of SHP2 and 4G10 (a phosphotyrosine antibody) in rosacea compared to normal tissue. IHC samples were graded according to an intensity scale (0-4). Mann-Whitney statistical analyses were performed via a dedicated computerized software package.
Results: On WB, SHP2 was expressed in higher concentrations in rosacea specimens ( < 0.05). On IHC, SHP2 was enriched in the epidermis in rosacea ( < 0.05), although 4G10 levels were not statistically significantly different between the two groups ( > 0.05).
Conclusions: SHP2 is enriched in cutaneous specimens of rosacea, suggesting a critical role for this protein in the disease and indicating a modifiable therapeutic moiety.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892417 | PMC |
http://dx.doi.org/10.1002/ski2.190 | DOI Listing |
Cell Death Dis
December 2024
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
The macrophage-associated inflammation response plays an important role in myocardial ischemia-reperfusion injury (MIRI). SHEP1(SH2 domain-containing Eph receptor-binding protein 1) has been implicated in adhesion and migration of inflammatory cells. However, the role and molecular mechanism of SHEP1 regulating macrophage remains unclear during MIRI.
View Article and Find Full Text PDFCells
November 2024
Department of Biochemistry and Molecular Genetics, Midwestern University, Glendale, AZ 85308, USA.
ACS Pharmacol Transl Sci
October 2024
Pharmacology Section, Department of Medicine and Surgery, University of Perugia, Perugia 06132, Italy.
Viruses
September 2024
Institute of Clinical and Molecular Virology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
The human cytomegalovirus (HCMV) glycoprotein B (gB) is the viral fusogen required for entry into cells and for direct cell-to-cell spread of the virus. We have previously demonstrated that the exchange of the carboxy-terminal domain (CTD) of gB for the CTD of the structurally related fusion protein G of the vesicular stomatitis virus (VSV-G) resulted in an intrinsically fusion-active gB variant (gB/VSV-G). In this present study, we employed a dual split protein (DSP)-based cell fusion assay to further characterize the determinants of fusion activity in the CTD of gB.
View Article and Find Full Text PDFTransl Cancer Res
August 2024
Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, China.
Background: Glioblastoma multiforme (GBM) is the most common and aggressive primary brain cancer in adults. This study aimed to obtain data on immune cell infiltration based on public datasets and to examine the prognostic significance of SH2 domain containing 4A () for GBM.
Methods: expression in GBM was analyzed using a Tumor Immunity Estimation Resource (TIMER) 2.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!